Dr. Jian’an Wang currently serves as the head of the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), as well as the Professor and Associate Dean of Zhejiang University School of Medicine. Under his leadership for over 10 years as a hospital president, SAHZU has been moved up to a top-ranking hospital in China.

As an experienced interventional cardiologist, he spearheaded the efforts in establishing and developing one of the biggest valvular heart disease programs in Asia and was invited to proctor TAVR procedure in Asia, Europe and South America. He has developed several CFDA approved innovative devices for valvular interventions in collaboration with engineers, CV colleagues and manufacturers. His bench side research focuses on improving the efficacy of stem cell implantation in infarcted myocardium.

Deeply engaged in activities of medical societies, he currently serves as the Vice Chairman of Chinese Cardiology Society and the Co-Chairman of Congenital Structural Interventions headquartered in Frankfurt, Germany. He is the inaugural Editor-in-Chief of JACC: Asia and World Journal of Emergency Medicine as well.